Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome
- PMID: 36056878
- DOI: 10.1093/eurheartj/ehac466
Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome
Conflict of interest statement
Conflict of interest: R.W. reports serving on the advisory boards of Abbott Vascular, Boston Scientific, Medtronic, Philips IGT, and Pi-Cardia Ltd; being a consultant for Abbott Vascular, Biotronik, Boston Scientific, Cordis, Medtronic, Philips IGT, Pi-Cardia Ltd, Swiss Interventional Systems/SIS Medical AG, Transmural Systems Inc, and Venous MedTech; receiving grant support from AstraZeneca, Biotronik, Boston Scientific, Chiesi, Medtronic, and Philips IGT; serving on the Speakers Bureau for AstraZeneca; and being an investor in MedAlliance and Transmural Systems Inc. The other authors have no conflict of interest to disclose.
Comment in
-
Timing of invasive strategy in non-ST-elevation acute coronary syndrome: risk and reward?Eur Heart J. 2022 Nov 21;43(44):4661. doi: 10.1093/eurheartj/ehac467. Eur Heart J. 2022. PMID: 36056880 No abstract available.
Comment on
-
Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.Eur Heart J. 2022 Sep 1;43(33):3148-3161. doi: 10.1093/eurheartj/ehac213. Eur Heart J. 2022. PMID: 35514079 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources